Market pricing and buying guide for palbociclib/palbociclib

Palbociclib, as a powerful kinase inhibitor, blocks the abnormal proteins that send proliferation signals to cancer cells, thereby curbing or slowing down the spread of cancer cells. It plays an important role in treating certain types of advanced breast cancer, which often rely on hormones such as estrogen to grow and have spread to other parts of the body.

When used in combination with an aromatase inhibitor, palbociclib can be used as initial treatment; and in combination with fulvestrant, it is also effective in treating breast cancer that has become resistant to anti-estrogens such as tamoxifen.

Currently, the original drug of palbociclib has been launched in China and has been included in the medical insurance system, but only patients who meet the indications can enjoy the reimbursement policy. Common drug specifications on the market include packaging of 75mg 21 capsules, 100mg 21 capsules and 125mg*21 capsules, with prices around RMB 5,000.

Original drugs tend to be more expensive for patients seeking to purchase them overseas. For example, the price of a medicine with a specification of 125mg*21 pills may be as high as 10,000 yuan per box (the specific price is affected by exchange rate fluctuations). However, overseas markets also offer generic drug options, which are basically the same ingredients as the brand-name drugs but are more affordable. For example, the price of a drug of the same specification produced by a Bangladeshi pharmaceutical factory may only be around 900 yuan (the price is also affected by the exchange rate).

When choosing purchase channels and drugs, patients should fully consider their own financial situation, the reliability of the drug source, and the doctor's advice to ensure the safety and effectiveness of treatment.